반응식
[OH:1][CH2:2][CH2:3][N:4]1[C:13]2[C:8](=[CH:9][C:10]([F:16])=[C:11](F)[C:12]=2[F:14])[C:7](=[O:17])[C:6]([C:18]([OH:20])=[O:19])=[CH:5]1.[N:21]1[CH:22]=[CH:23][N:24]2[CH2:29][CH2:28][NH:27][CH2:26][C:25]=12>>[OH:1][CH2:2][CH2:3][N:4]1[C:13]2[C:8](=[CH:9][C:10]([F:16])=[C:11]([N:27]3[CH2:28][CH2:29][N:24]4[CH:23]=[CH:22][N:21]=[C:25]4[CH2:26]3)[C:12]=2[F:14])[C:7](=[O:17])[C:6]([C:18]([OH:20])=[O:19])=[CH:5]1참가 물질
3
실험 절차
Using 1-(2-hydroxyethyl)-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine, the same procedure as in Production Example 1 was followed to yield the title compound.
출처 및 근거
- ORD 기록
- ord-8d763b311eee4bb6aaa044f470ff820d
- 출처 데이터셋
- uspto-grants-1999_03
- 특허 번호
- US05889009
연결된 노트
불러오는 중…